Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Genotype 1a”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Large-scale testing (Phase 3)Study completedNCT02487199
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 18
Post-approval studies (Phase 4)Ended earlyNCT03797066
What this trial is testing

ATTIC - Access To Treat in the Community

Who this might be right for
Hepatitis C, Chronic
King's College Hospital NHS Trust 13
Testing effectiveness (Phase 2)Study completedNCT01724086
What this trial is testing

Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C Virus

Who this might be right for
Chronic Hepatitis C
Janssen R&D Ireland 90
Not applicableStudy completedNCT02098616
What this trial is testing

Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus

Who this might be right for
Hepatitis C
Timothy Morgan, MD 25
Testing effectiveness (Phase 2)Study completedNCT02493855
What this trial is testing

Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults

Who this might be right for
Chronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1a
AbbVie 46
Large-scale testing (Phase 3)Study completedNCT02609659
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 105
Large-scale testing (Phase 3)Study completedNCT01833533
What this trial is testing

Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1a Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 305
Large-scale testing (Phase 3)Study completedNCT02476617
What this trial is testing

Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults

Who this might be right for
Chronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1a
AbbVie 25
Testing effectiveness (Phase 2)Study completedNCT01859962
What this trial is testing

Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Presidio Pharmaceuticals, Inc. 38
Post-approval studies (Phase 4)Study completedNCT01937728
What this trial is testing

Tailored Regimens of PEGASYS® and Ribavirin for Genotype 1 Chronic Hepatitis C Patients Trial (TARGET-1)

Who this might be right for
Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital 542
Testing effectiveness (Phase 2)Study completedNCT01581138
What this trial is testing

VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C

Who this might be right for
Chronic Hepatitis C Virus
Vertex Pharmaceuticals Incorporated 64
Testing effectiveness (Phase 2)Study completedNCT01435226
What this trial is testing

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 170
Early research (Phase 1)Study completedNCT01928147
What this trial is testing

A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients

Who this might be right for
Hepatitis C, Chronic
Presidio Pharmaceuticals, Inc. 114
Not applicableStudy completedNCT01342003
What this trial is testing

HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b

Who this might be right for
Chronic Hepatitis C
Azienda Ospedaliera San Camillo Forlanini 388
Testing effectiveness (Phase 2)Ended earlyNCT01384383
What this trial is testing

GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 248
Testing effectiveness (Phase 2)Study completedNCT01434498
What this trial is testing

GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Genotype 1a or 1b HCV Infection
Gilead Sciences 163